Galderma to Acquire ZO Skin Health for $1.5 Billion

Acquisition brings together two highly complementary, science-backed skincare brands ZO Skin Health’s premium daily multi-step regimens complement...

October 15, 2026 | Thursday | News
Rhythm Pharmaceuticals Launches IMCIVREE in Japan for Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living ...

October 15, 2026 | Thursday | News
Piramal Pharma Solutions Opens New Microbiology Laboratory at Kentucky Sterile Injectables Facility

The new microbiology laboratory and sterility testing suite are designed for GMP drug product applications. This addition is part of the broader Lexingt...

October 07, 2026 | Wednesday | News
Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...

October 05, 2026 | Monday | News
SkinHealth Systems Expands SkinStylus Microneedling Device Across Six European Markets

SkinHealth Systems (Nasdaq: SKIN), home to flagship brand Hydrafacial™, announced the European expansion of the SkinStylus® SteriLock® MicroS...

October 02, 2026 | Friday | News
Mironid Doses First Patients in Phase 1 Trial of LoAc® Therapy for ADPKD

Phase 1 study is evaluating the safety, tolerability and pharmacokinetics of Mironid’s lead LoAc® small molecule in healthy volunteers Dosing ...

October 02, 2026 | Friday | News
Rakovina Therapeutics and Celvion Partner to Advance AI-Driven Precision Cancer Therapies

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF) a biopharmaceutical company advancing innovative cancer therapies through AI-powered d...

October 02, 2026 | Friday | News
Verdiva Bio Presents VRB-103 Oral Amylin Data for Obesity Treatment

Verdiva Bio Limited (“Verdiva Bio” or “the Company”), a clinical-stage biotechnology company advancing the development of a portfol...

September 30, 2026 | Wednesday | News
Codexis Partners with siRNA Innovator to Advance Enzymatic Oligonucleotide Manufacturing

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced an agreement with ...

September 30, 2026 | Wednesday | News
ACROBiosystems Expands French Presence With New Hub at Kadans Science Partner’s The HIVE

Kadans Science Partner is pleased to welcome ACROBiosystems to The HIVE Innovation Center, its laboratory and office building dedicated to the life scien...

September 25, 2026 | Friday | News
Lōkahi Therapeutics and University of Alabama Extend Biopharma Asset Evaluation Collaboration

Lōkahi Therapeutics, a subsidiary of Glucotrack, Inc., announced that The University of Alabama’s Culverhouse College of Business will continue it...

September 22, 2026 | Tuesday | News
Cue Biopharma Reports Positive Phase 2 Results for CUE-221 in Chronic Spontaneous Urticaria

  Cue Biopharma, a clinical-stage biopharmaceutical company targeting transformative therapies for immune-mediated diseases, announced positive topli...

September 22, 2026 | Tuesday | News
Telix Pharmaceuticals to Lead Merger With ITM to Create Vertically Integrated Radiopharmaceutical Leader

Telix Pharmaceuticals Limited announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE (“ITM”),...

September 22, 2026 | Tuesday | News
XORTX Therapeutics Targets Q4 2026 FDA IND Submission for XRx-026 Gout Program

XORTX Therapeutics Inc. (“XORTX” or the “Company”), a late-stage clinical pharmaceutical company focused on developing innov...

September 21, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close